Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |